Member Info for Ghia

Nolupus - I was surprised to see 32.8, i'm not sure if you follow charting at all but there was apparently a gap at this level from March I know many chartists are happy to see it filled.

The fizz is returning to the Covid Market should help us rise nicely into results.

The world does not have the controls in place to contain this virus more cases in NZ probably imported, AZN suggest vaccine might give 12month protection.

It is looking like we will have to learn to live with this virus like we live with the flu. COPD patients hugely at risk that market has just got even more lucrative IMO.

Covid Round 1 went the way of NCYT

Covid Round 2 has GDR written all over it the quality of the test will be and is being recognised. I think it also hits the right price point, both cost for the test and the logistics of moving it and storing it.

I'm fully expecting some very solid contracts to be coming our way.

DubleD- I gather you are here till results so we will have the opportunity to reflect at that point, hopefully for both our sakes everything is above board.

On good results I would expect a higher caliber of financing and deals to be done so the days of distressed sellers would likely be behind us.

Seb - What are you taking as your entry price for IAG? I’ll happily double or quits with today’s closing price...

DubleD - If you are implying the offloading is due to a leak I think you are mistaken.

Firstly I think our BOD is too professional Secondly this sell down has been far too controlled and prolonged.

A bad leak would have sent this crashing so fast.

This has been a slow steady sustained drop fuelled by II’s but aided by nervous PI’s meanwhile the free float of shares is being sucked up by someone.

I wonder how many 2.9% holdings exist scattered around.

For those that like charts supposedly we filled a gap from Match today.

Nolupus - Agreed money management is key how you go about that can vary hugely.

Might surprise you to know I have zero capital in this share so whilst sitting on a hefty paper loss it’s a paper loss on crystallised profits from stock market gains.

I can afford to double down here as long as I reduce risks in other areas of my finances I’ve spent last week selling out of a number of p2p loans.

Nolupus - I’m trying to take emotion out of this one and trade what I see.

My emotional side would say I’m ****ed off at what’s happened here and not invest more.

My rational side is actually saying buy more. That won’t be everyone’s conclusion but I’m happy to be betting against the market on this one.

Speculative limit buys in place to take advantage of any minor wobbles that might get thrown our way tomorrow.

Nothing major but several price points I’d be ecstatic if they all get filled.

If the market wants to **** all over the share price here I’m sure as hell gonna make sure I benefit.

If the results for SNG are good there will be plenty of money from philanthropic organisations to supply poorer nations with supplies.

The tax payer will fund the UK the insurance companies will fund the US.

I'm still wondering how 3% of the company can be traded in 2 trades on Friday and no TR1? Surely they went to the same organisation.

Blessed - The drop is painful the II's have done us no favours. I've always maintained nothing has materially changed well today something did change another drug has shown to be effective in a trial that appears to have been run above board with decent data.

If that negatively effects us short term so be it what it has shown is that good results on good data make national headlines instantly. No one drug will be a silver bullet and thankfully this drug seems to be focused where SNG are not.

For once the government is talking treatment not vaccine roll on our results.

Blessed - I think you are confusing % rises with value. The value of successful results will be determined by whatever licensing and partnering deals are struck.

The starting point of the share price does not effect the value, but it does effect the potential upside.

Exactly the news today is fantastic for the whole world, an inexpensive drug that can really help in the later stages of infection. Music to the ears of the likes of India Africa etc.

SNG are attacking the problem at the other end of the scale preventing people getting into the situation in the first place. Arguably the more profitable end of the scale and could eliminate the need for hospitalization which provides cost savings in itself.

Coshman - Agreed maybe a little excitement will brew as June closes out but everyone is just waiting for the results now. If COPD was available they might want to push that out before the AGM end of the month.

coshman - The sun is shining the Governement will actively encourage people to get out and spend to save the economy and perhaps the inherent risks of a second wave will be swept under the carpet for a while.

Meanwhile SNG will release their trial data (hopefully positive) license, manufacture and when the second wave slams us in the face in conjunction with the autumn/winter flu season we'll be in high demand. I can't see emergency use authorisation not granted if the second wave hits and we have had good trial results.

Agreed Henderz - At least here we have a ticking clock, COPD could land anytime from next week onwards Hospital Trial is likely to be 16th July onwards.

With the exception of a few the other Covid Plays are on looser timelines that keep getting kicked from spring to summer next will be autumn etc.

Have DDDD filled their trial yet? Don't under estimate the significance of us filling the Hospital Trial in a timely fashion a few weeks delay at the start of the trial and we would have really been struggling to fill here.

Same Goose - Rightly or wrongly I’m in until results. No sauce for me tonight the unexpected Sunday afternoon sun made for a mighty Monday morning headache.

Personally all I have heard coming out of AVCT regarding COVID was Jam tomorrow. I’ve given this share a wide berth on purpose and I fear for once I may have been correct.

The value here is the affirmer tech and it will have its day but be prepared to sit on your shares for a year or so.

Good news is they are fully funded now for several years. Once Covid blows through and we learn how to live with it AVCT will be on my radar as an investment.

Too much hot air in this one surrounding covid for my liking currently.